Who is sponsoring NCT01860274?

NCT01860274 is sponsored by Cardiochirurgia E.H..

What drugs are being tested in NCT01860274?

Interventions in NCT01860274: External Mesh for vein grafts.

What condition does NCT01860274 study?

NCT01860274 studies Coronary Artery Disease.

Is NCT01860274 still recruiting?

NCT01860274 is currently completed. Last updated 12 March 2021.

Last reviewed 2021-03-12 · How we verify

NCT01860274

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Meshed Vein Graft Patency Trial - VEST

Completed NA Last updated 12 March 2021

What this trial tests

NA trial testing External Mesh for vein grafts in Coronary Artery Disease in 102 participants. Completed in 28 June 2020.

Timeline

6 September 2015

Primary endpoint
31 December 2019

28 June 2020

Quick facts

Lead sponsor	Cardiochirurgia E.H.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	102
Start date	6 September 2015
Primary completion	31 December 2019
Estimated completion	28 June 2020
Sites	2 locations across Italy

Drugs / interventions tested

External Mesh for vein grafts

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →

Sponsor

Cardiochirurgia E.H. — full company profile →

Who can join

Eligibility, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study hypothesis is that a meshed conduit made of safen vein allows a better patency at mid-long term than a safen vein alone. To test this hypothesis the investigators plan a prospective, randomized study, comparing grafts to the diagonal, in cases of vessel diameter under 1.5mm. A control angiography will be performed one year after the operation.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

External stenting of vein grafts in coronary artery bypass grating: interim results from a two centers prospective study.
Weltert LP, Audisio K, Bellisaro A, Bardi G, et al · · 2021 · cited 6× · PMID 33845865 · DOI 10.1186/s13019-021-01406-0
External Stenting of Vein Grafts in Coronary Artery Bypass Grating: Interim Results from a Two Centers Prospective Study
Weltert L, Audisio K, Bellisaro A, Bardi G, et al · · 2021 · DOI 10.21203/rs.3.rs-62859/v2

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Cardiochirurgia E.H. trials

Trials by the same sponsor.

NCT07038330 — DOSE FINDING PROSPECTIVE ANALYSIS AFTER HEART SURGERY for Sucrosomial Iron · Phase 4 · not yet recruiting
NCT06877195 — Multicenter Randomised Prospective Study for External Support Mesh VEST of Venous Coronary Grafts on the Right Territory · NA · recruiting
NCT05574621 — ITA Vs LAD; Evaluation of Inflammatory Burden in OP-CABG Patients · completed
NCT03961425 — CO2 Field Saturating Alternative Techniques Comparison · NA · completed
NCT03560687 — CardioSideral Heart Surgery: Randomized Study on Sucrosomial Iron Supplementation Before Heart Surgery · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01860274 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cardiochirurgia E.H.
Last refreshed: 12 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01860274.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing